@FierceBiotech: Mayo Clinic to launch center for social media. Report | Follow @FierceBiotech
@JohnCFierce: It's rare to see a Phase III drug with the kind of compelling, clean profile that telaprevir has. | Follow @JohnCFierce
> The vaccine developer Medicago, which is making vaccines from tobacco plants, is investing $32 million in a new production facility in Research Triangle Park. The project will lead to the creation of 85 new jobs. Report
> Shares of SciClone Pharmaceuticals plunged after the company said that the feds are investigating its business activities in China. Article
> The UK's Tissue Regenix has received its first approval, gaining the European CE mark for a new patch designed to promote tissue repair. The dCELL vascular patch uses human and animal cells to create a scaffold for tissue regeneration. And the company says it is now pursuing an FDA approval as well. Tissue Regenix went public through a reverse merger in June. It makes the patch, which is designed to avert the use of anti-rejection therapies, in York. Story
> The startup Zurex Pharma, which is developing antimicrobial products, set up shop in Madison, WI. Item
> Nabi has earned an $8 million milestone from its sale of PentaStaph (Pentavalent S. aureus Vaccine) and related assets to GSK. Nabi release
> Syndax Pharmaceuticals has raised $6 million from 12 investors. Story
> AVI BioPharma revealed that it paid $2.6 million to its ex-CEO, Leslie Hudson, huirting its second quarter results. Hudson left the company in April and the CFO is serving as interim CEO. News
And Finally... Fresh research shows that a big waist is a big risk. Report